Healthcare / Health Information ServicesASX
$0.11
+0.00 (+2.33%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-285000.00 · quality 45.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
35/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$148M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-9.7%
↓Gross Margin
86.1%
↑Debt/Equity
0.02
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+12.7%
FCF CAGR
—
FCF margin
-19.4%
FCF / Net income
0.85x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $37.1M · net income $-8.4M · FCF $-7.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $37.1M | $37.1M | $40.4M | $34.4M | $25.9M |
| Net Income | $-8.4M | $-8.4M | $-3.6M | $-4.4M | $-2.2M |
| EBITDA | $-4.5M | $-4.5M | $-1.4M | $-1.6M | $-474000.00 |
| EPS | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Gross Margin | 86.1% | 86.1% | 86.1% | 85.8% | 88.3% |
| Operating Margin | -23.4% | -23.4% | -11.7% | -5.0% | -1.7% |
| Net Margin | -22.7% | -22.7% | -9.0% | -12.8% | -8.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.02 | 0.02 | 0.02 | 0.03 | 0.00 |
| Current Ratio | 1.28 | 1.28 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-7.2M | $-7.2M | $-285000.00 | $685000.00 | $1.2M |
| Returns | |||||
| ROE | -9.7% | -9.7% | -4.0% | -4.7% | -5.0% |
| Valuation | |||||
| P/B | 1.67 | 1.67 | 1.38 | 1.55 | 8.69 |
| Growth & Yield | |||||
| Revenue Growth | -8.3% | -8.3% | 17.6% | 32.7% | — |
| EPS Growth | -120.7% | -120.7% | 23.7% | -76.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+15.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.00 → -0.01
Residual
+15.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.